Ambee Pharmaceuticals (DHA:AMBEEPHA) Liabilities-to-Assets : 0.00 (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:AMBEEPHA Ambee Pharmaceuticals Plc DHA:AMBEEPHA
18 GF Score
Price BDT748.50
View Full Analysis

What is Ambee Pharmaceuticals Liabilities-to-Assets?

Ambee Pharmaceuticals DHA:AMBEEPHA -0.23% 18 Liabilities-to-Assets is 0.00 as of . 20. GuruFocus rates DHA:AMBEEPHA with a GF Score™ of 18/100.

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Ambee Pharmaceuticals's Total Liabilities for the quarter that ended in . 20 was BDT0.00 Mil. Ambee Pharmaceuticals's Total Assets for the quarter that ended in . 20 was BDT0.00 Mil.

Ambee Pharmaceuticals  (DHA:AMBEEPHA) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.

Ambee Pharmaceuticals Liabilities-to-Assets Related Terms

Ambee Pharmaceuticals Liabilities-to-Assets Historical Data

* Premium members only.

The historical data trend for Ambee Pharmaceuticals's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ambee Pharmaceuticals Liabilities-to-Assets Chart

Ambee Pharmaceuticals Annual Data
Trend
Liabilities-to-Assets

Ambee Pharmaceuticals Semi-Annual Data
Liabilities-to-Assets

DHA:AMBEEPHA vs IMNPQ: Liabilities-to-Assets Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ambee Pharmaceuticals's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ambee Pharmaceuticals Liabilities-to-Assets vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ambee Pharmaceuticals's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Ambee Pharmaceuticals's Liabilities-to-Assets falls into.


DHA:AMBEEPHA
18GF Score
Ambee Pharmaceuticals Plc DHA:AMBEEPHA
Liabilities-to-Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ambee Pharmaceuticals Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Ambee Pharmaceuticals's Liabilities-to-Assets Ratio for the fiscal year that ended in . 20 is calculated as:

Liabilities-to-Assets (A: . 20 )=Total Liabilities/Total Assets
=/
=N/A

Ambee Pharmaceuticals's Liabilities-to-Assets Ratio for the quarter that ended in . 20 is calculated as

Liabilities-to-Assets (Q: . 20 )=Total Liabilities/Total Assets
=/
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Liabilities-to-Assets →
What does a Liabilities-to-Assets of 0.00 mean?
Ambee Pharmaceuticals (DHA:AMBEEPHA) has a Liabilities-to-Assets of 0.00 as of . 20. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on Ambee Pharmaceuticals and its competitors.
Is Ambee Pharmaceuticals' Liabilities-to-Assets too high?
Ambee Pharmaceuticals' current Liabilities-to-Assets is 0.00. Overall, Ambee Pharmaceuticals has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Ambee Pharmaceuticals' Liabilities-to-Assets compare to IMNPQ?
Ambee Pharmaceuticals' Liabilities-to-Assets of 0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Liabilities-to-Assets for a Drug Manufacturers company?
A good Liabilities-to-Assets depends on the Drug Manufacturers industry context. However, Liabilities-to-Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Liabilities-to-Assets mean?
A high Liabilities-to-Assets can signal that a stock is expensive relative to its fundamentals. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on Ambee Pharmaceuticals and its competitors. Ambee Pharmaceuticals's current Liabilities-to-Assets is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambee Pharmaceuticals stock overvalued right now?
Ambee Pharmaceuticals (DHA:AMBEEPHA) has a current Liabilities-to-Assets of 0.00. The current Liabilities-to-Assets is 0.00. Ambee Pharmaceuticals' overall GF Score™ is 18/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Liabilities-to-Assets calculated?
Liabilities-to-Assets is calculated from a company's financial statements. For Ambee Pharmaceuticals (DHA:AMBEEPHA), the current Liabilities-to-Assets is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ambee Pharmaceuticals Business Description

Address 184/1 Tejgaon Industrial Area, Dhaka, BGD, 1208
Ambee Pharmaceuticals Plc formerly Ambee Pharmaceuticals Ltd manufactures a wide range of pharmaceutical products in Bangladesh. It is engaged in the business of manufacturing drugs and medicine and sales. Its products are sold in the form of tablets, capsules, liquids, gels, and injectables.
18GF Score

Get the complete analysis for DHA:AMBEEPHA

Liabilities-to-Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT748.50
Price